로딩 중…
지수 로딩 중…
Phathom Pharmaceuticals, Inc.
PHAT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$10.88-1.09%
2026-06-18
Price Chart
Phathom Pharmaceuticals, Inc.-0.18%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $868M |
| Revenue | $205M |
| Net Income | $-157M |
| Total Assets | $305M |
| Net Assets | $72M |
| Value | |
| P/B | 12.03x |
| P/S | 4.24x |
| FCF Yield | -11.24% |
| Profitability | |
| ROA | -51.55% |
| Op. Margin | -47.15% |
| Revenue Growth | 104.43% |
| Financial Health | |
| Debt Ratio | 889.84% |
| Total Debt | $3M |
| FCF | $-98M |
| Cash | $181M |
| Current Ratio | 2.21x |
| Performance | |
| 1Y Return | -0.18% |
| 1M Return | -4.56% |
| From 52W High | -40.58% |
| 1Y MDD | -48.89% |
| Trading | |
| Volume | 1,005,610 shares |
| Trading Value | $11M |
| Per Share | |
| EPS | $-3.03 |